BioVaxys Announces Application for Management Cease Trade Order
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of ...
BioVaxys Technology Corp.: BioVaxys Announces Application for Management Cease Trade Order
Anticipates Late Filing of Annual Financial Statements - VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") ...
precisionmedicineonline7h
BC Cancer Foundation Launches C$6.8M Campaign to Advance CAR T-Cell Therapies
The foundation hopes to put the funds toward two clinical programs in blood cancers and one preclinical project in solid tumors.